1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine
- Product Name
- 1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine
- CAS No.
- 831234-13-0
- Chemical Name
- 1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine
- Synonyms
- AC1903;AC1903 ，S0977;AC1903 AC-1903;AC1903 >=98% (HPLC);AC1903, 10 mM in DMSO;1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine;1-Benzyl-N-(2-furylmethyl)-1H-benzimidazol-2-amine;1-benzyl-N-(furan-2-ylmethyl)-1H-benzo[d]imidazol-2-amine;1-Benzyl-N-[(furan-2-yl)methyl]-1H-1,3-benzodiazol-2-amine;1H-Benzimidazol-2-amine, N-(2-furanylmethyl)-1-(phenylmethyl)-
- CBNumber
- CB14243558
- Molecular Formula
- C19H17N3O
- Formula Weight
- 303.36
- MOL File
- 831234-13-0.mol
1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine Property
- Boiling point:
- 512.4±60.0 °C(Predicted)
- Density
- 1.20±0.1 g/cm3(Predicted)
- storage temp.
- -20°C
- solubility
- Soluble in DMSO (up to 30 mg/ml) or in Ethanol (up to 25 mg/ml)
- pka
- 6.09±0.10(Predicted)
- form
- solid
- color
- Beige
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
- InChI
- InChI=1S/C19H17N3O/c1-2-7-15(8-3-1)14-22-18-11-5-4-10-17(18)21-19(22)20-13-16-9-6-12-23-16/h1-12H,13-14H2,(H,20,21)
- InChIKey
- OECUWHDVQIITIS-UHFFFAOYSA-N
- SMILES
- C1(NCC2=CC=CO2)N(CC2=CC=CC=C2)C2=CC=CC=C2N=1
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P271Use only outdoors or in a well-ventilated area.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P330Rinse mouth.
P332+P313IF SKIN irritation occurs: Get medical advice/attention.
P337+P313IF eye irritation persists: Get medical advice/attention.
P362Take off contaminated clothing and wash before reuse.
P403+P233Store in a well-ventilated place. Keep container tightly closed.
P405Store locked up.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- 25324
- Product name
- AC1903
- Purity
- ≥95%
- Packaging
- 5mg
- Price
- $49
- Updated
- 2024/03/01
- Product number
- 25324
- Product name
- AC1903
- Purity
- ≥95%
- Packaging
- 10mg
- Price
- $87
- Updated
- 2024/03/01
- Product number
- 6766
- Product name
- AC1903
- Purity
- ≥98%(HPLC)
- Packaging
- 25
- Price
- $275
- Updated
- 2021/12/16
- Product number
- orb546177
- Product name
- AC1903
- Purity
- >98%
- Packaging
- 10mg
- Price
- $190.4
- Updated
- 2021/12/16
- Product number
- CS-0081483
- Product name
- AC1903
- Purity
- 98.64%
- Packaging
- 25mg
- Price
- $240
- Updated
- 2021/12/16
1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine Chemical Properties,Usage,Production
Description
AC1903 is an inhibitor of transient receptor potential canonical channel 5 (TRPC5; IC50 = 14.7 μM). It is selective for TRPC5 over TRPC4 and TRPC6 at concentrations up to 100 and 30 μM, respectively. It inhibits TRPC5 in a concentration-dependent manner in HEK293 cells when used at concentrations ranging from 1 to 100 μM. AC1903 (30 μM) inhibits angiotensin II-induced production of reactive oxygen species (ROS) in wild-type podocytes and podocytes expressing a mutant angiotensin II type 1 (AT1) receptor that cannot be inactivated and endocytosed. It also suppresses proteinuria as well as reduces pseudocyst formation and podocyte loss in an AT1 receptor transgenic rat model of kidney disease when administered at a dose of 50 mg/kg twice per day. In a model of hypertension-induced focal segmental glomerulosclerosis (FSGS) using Dahl salt-sensitive rats, AC1903 decreases the rate of proteinuria when administered at the beginning of a high-salt diet and prevents progression when administered one week following initiation of a high-salt diet.
Uses
AC1903 is a TRPC5 inhibitor with valuable potential for the treatment of progressive kidney diseases. AC1903 inhibits TRPC5 ion channels and suppresses progressive kidney diseases via TRPC5-AT1R related genetic pathways. ?AC1903 also provides therapeutic benefit in a rat model of hypertensive proteinuric kidney disease.
in vivo
AC1903 (intraperitoneal injection; 50 mg/kg; twice per day; 7 days) significantly suppresses proteinuria as well as reduces pseudocyst formation and podocyte loss in an AT1 receptor transgenic rat model of kidney disease[1].AC1903 (intraperitoneal injection; 50 mg/kg; twice per day; initiated on day 7 and treated for 1 week until day 14) initiatation on day 7 exhibits significant suppression of proteinuria with preserved podocyte numbers. Besides, AC1903 does not affect the mean arterial pressure (MAP) and exhibits no effect on body weight, blood urea nitrogen, or creatinine in Dahl S rats[1].
| Animal Model: | Hypertension-induced focal segmental glomerulosclerosis (FSGS) model in Dahl salt-sensitive rats[1] |
| Dosage: | 50 mg/kg |
| Administration: | Intraperitoneal injection; 50 mg/kg; twice per day; 7 days |
| Result: | Inhibited the progression of proteinuric kidney disease by preserving podocytes. |
| Animal Model: | 6-week-old Dahl S rats received 2% NaCl for 1 week with severe, progressive proteinuric disease[1] |
| Dosage: | 50 mg/kg |
| Administration: | Intraperitoneal injection; 50 mg/kg; twice per day; initiated on day 7 and treated for 1 week until day 14 |
| Result: | Decreased the rate of proteinuria when administered at the beginning of a high-salt diet and prevents progression when administered one week following initiation of a high-salt diet. |
storage
Store at -20°C
References
[1] YIMING ZHOU. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models[J]. Science, 2017, 358 6368. DOI:10.1126/science.aal4178
1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine Preparation Products And Raw materials
Raw materials
Preparation Products
1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine Suppliers
- Tel
- 0512-65118909 18100677375
- sales@szzxbio.com
- Country
- China
- ProdList
- 2993
- Advantage
- 58
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
- Tel
- 0513-85921823 18662920231
- Fax
- 86-513-85012876
- sales@ntminyanmedical.com
- Country
- China
- ProdList
- 4113
- Advantage
- 58
- Tel
- 021-52996696，15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4768
- Advantage
- 55
- Tel
- 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 9923
- Advantage
- 65
- Tel
- 13764913901
- Fax
- -
- info@angtibio.com
- Country
- China
- ProdList
- 4984
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 021-31433387 15618786686
- Fax
- QQ:1369748377
- sales@rechemscience.com
- Country
- China
- ProdList
- 2991
- Advantage
- 58